1999
DOI: 10.1006/bbrc.1998.0131
|View full text |Cite
|
Sign up to set email alerts
|

Manganese Dipyridoxyl Diphosphate: MRI Contrast Agent with Antioxidative and Cardioprotective Properties?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
41
0

Year Published

1999
1999
2017
2017

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 63 publications
(44 citation statements)
references
References 20 publications
3
41
0
Order By: Relevance
“…Furthermore, ONC may cause the release of free radicals that cause oxidative stress and cellular damage (37). Mn 2ϩ has the ability to act as a scavenger, protecting RGCs against oxidative stress (38,39). Since more RGCs survive after serial intravitreal injection of 150 nmol MnCl 2 at 0 and 20 dpl than after ONC alone, it seems that MEMRI safely can be used to study regeneration in the ON after ONC in the manner presented here.…”
Section: ؉ Toxicity On Rgc Survival After Onc and Png Implantationmentioning
confidence: 88%
“…Furthermore, ONC may cause the release of free radicals that cause oxidative stress and cellular damage (37). Mn 2ϩ has the ability to act as a scavenger, protecting RGCs against oxidative stress (38,39). Since more RGCs survive after serial intravitreal injection of 150 nmol MnCl 2 at 0 and 20 dpl than after ONC alone, it seems that MEMRI safely can be used to study regeneration in the ON after ONC in the manner presented here.…”
Section: ؉ Toxicity On Rgc Survival After Onc and Png Implantationmentioning
confidence: 88%
“…Mangafodipir has pharmacological effects, including anti-oxidant [4,9,14], antitumour [8,9] and anti-apoptotic activities [10]. Additionally, the mangafodipir metabolites MnPLED and Dp-dp have also been shown to possess anti-oxidant and metal ion-chelating effects [7].…”
Section: Discussionmentioning
confidence: 99%
“…Potential use of mangafodipir for cardiovascular MRI was suggested, as it exerts pharmacological effects such as vascular relaxation and protection against oxidative stress [4]. Mangafodipir was marketed as Teslascan and supplied as sterile aqueous solution with a recommended adult dose of 5 µmol/kg body weight [5].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the use of a Mn 2+ -releasing contrast agents such as Mn-DPDP may be a promising multipurpose approach. In addition to the suggested therapeutic effects of antioxydative myocardial protection (Brurok et al 1999;Karlsson et al 2001), with noninvasive MRI, more functional information about myocardial metabolism and MV might be acquired by depicting differential patterns of T1 relaxation changes in relation to regional coronary flow, cellular cation uptake and retention, ion channel function and metabolism in patients with coronary heart disease. However, all these encouraging outcomes are still experimental.…”
Section: Intracellular Contrast Agentsmentioning
confidence: 99%